CYCLERION THERAPEUTICS INC (CYCN) Stock News
NASDAQ:CYCN - Nasdaq - US23255M2044 - Common Stock - Currency: USD
CYCN Latest News, Press Relases and Analysis
Top movers in Monday's session
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
The trading volume of these stocks is deviating from the norm in today's session.
Let's have a look at what is happening on the US markets on Monday. Below you can find the stocks with an unusual volume in today's session.
Keep an eye on the top gainers and losers in Monday's session.
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
Cyclerion Has Renegotiated Praliciguat License Agreement to Obtain Upfront and Near-Term Payments as well as Entered into a License Option Agreement for Olinciguat
Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
Cyclerion is leveraging its legacy sGC stimulator assets to generate near-term revenues which will be used to implement its strategic building plan....
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Regina Graul, Ph.D., has been promoted to Chief Executive Officer, President, and member of the Board of Directors of Cyclerion....
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024
Cyclerion Therapeutics just reported results for the first quarter of 2024.
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023
Cyclerion Therapeutics just reported results for the fourth quarter of 2023.
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cyclerion Therapeutics (NASDAQ:CYCN) just reported results for the fourth quart...
Cyclerion Appoints Regina Graul, Ph.D., as President
Cyclerion Appoints Regina Graul, Ph.D., as President
– Dr. Graul will lead the rebuild of Cyclerion, bringing more than two decades of drug making experience, R&D portfolio leadership, and a deep...